Company Overview

Apellis Holdings, LLC is a biopharmaceutical company focused on the development and commercialization of novel therapies for patients with serious autoimmune and inflammatory diseases. Their lead product candidate, pegcetacoplan, is being studied in Phase 3 clinical trials for multiple rare and autoimmune diseases. With a deep pipeline of potential therapies, Apellis is dedicated to improving the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#3 in Crestwood, KY

#340 in Kentucky

#60,641 in US

Crestwood, KY, United States of America

Apellis Holdings, LLC

Forward Citations = 39

2 inventors:

Cedric Francois (4 out of 43 patents)

Angus McLachlan (4 out of 6 patents)

Angus Mclachlan (1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apellis Holdings, LLC. Retrieved from https://idiyas.com/company/apellis-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]